Treace Medical Concepts, Inc.
TMCI
$6.45
-$0.07-1.07%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 68.71M | 45.09M | 44.46M | 51.11M | 62.21M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 68.71M | 45.09M | 44.46M | 51.11M | 62.21M |
| Cost of Revenue | 13.23M | 8.95M | 8.78M | 10.13M | 11.47M |
| Gross Profit | 55.48M | 36.13M | 35.67M | 40.98M | 50.74M |
| SG&A Expenses | 50.47M | 46.30M | 51.90M | 54.69M | 53.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 68.86M | 60.22M | 65.84M | 70.02M | 68.99M |
| Operating Income | -151.00K | -15.13M | -21.38M | -18.92M | -6.78M |
| Income Before Tax | -501.00K | -15.36M | -21.21M | -18.68M | -6.28M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -501.00K | -15.36M | -21.21M | -18.68M | -6.28M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -501.00K | -15.36M | -21.21M | -18.68M | -6.28M |
| EBIT | -151.00K | -15.13M | -21.38M | -18.92M | -6.78M |
| EBITDA | 1.09M | -12.98M | -19.27M | -17.01M | -5.51M |
| EPS Basic | -0.01 | -0.25 | -0.34 | -0.30 | -0.10 |
| Normalized Basic EPS | 0.00 | -0.15 | -0.21 | -0.19 | -0.06 |
| EPS Diluted | -0.01 | -0.25 | -0.34 | -0.30 | -0.10 |
| Normalized Diluted EPS | 0.00 | -0.15 | -0.21 | -0.19 | -0.06 |
| Average Basic Shares Outstanding | 62.34M | 62.23M | 62.08M | 61.79M | 61.70M |
| Average Diluted Shares Outstanding | 62.34M | 62.23M | 62.08M | 61.79M | 61.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |